Sort
17,288 grants matching “multiple sclerosis”
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease
$389,819Paul Joseph Tesar · Case Western Reserve University · R01 · FY2015 · NS
Molecular Basis of Neuron-Gila Interactions in the CNS
$389,810Gabriel Corfas · Boston Children'S Hospital · R01 · FY2008 · NS
Phase II Trial of methotrexate in myasthenia gravis FDA IND#:101,306 01/06/2008
$389,739Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2011 · FD
The Effects of Alcohol on JNK Mediated Inflammatory Signaling in Glial Cells
$389,698Jack L. Leonard · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · AA
Genetic and MRI correlates of humoral immunity to myelin
$389,586Claude Paul Genain · California Pacific Med Ctr Res Institute · R01 · FY2008 · NS
Improving multiple sclerosis patient quality of life using microneedle patches to simplify delivery of MS drugs
$389,508Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2022 · AI
Molecular Recognition of Ligand by the Gamma Delta T Cell Receptor
$389,432Erin June Adams · University Of Chicago · R01 · FY2015 · AI
Molecular Recognition of Ligand by the Gamma Delta T Cell Receptor
$389,432Erin June Adams · University Of Chicago · R01 · FY2014 · AI
Molecular Recognition of Ligand by the Gamma Delta T Cell Receptor
$389,432Erin June Adams · University Of Chicago · R01 · FY2016 · AI
Molecular Recognition of Ligand by the Gamma Delta T Cell Receptor
$389,432Erin June Adams · University Of Chicago · R01 · FY2012 · AI
Calibrating Transcutaneous Spinal Stimulation for Spasticity, Pain, and Motor Function in SCI
$389,424Edelle Carmen Field-Fote · Shepherd Center · R01 · FY2022 · HD
Experimental Optic Neuritis: Gene Therapy
$389,423John R Guy · University Of Miami School Of Medicine · R01 · FY2008 · EY
Role of regulatory CD4+CD25+ T cells in diabetes
$389,233Brigham And Women'S Hospital · U01 · FY2004 · DK
Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation
$389,230Caroline Niziolek · University Of Wisconsin-Madison · R01 · FY2025 · DC
Novel Regulation and Targeting of Macrophages Metabolism in Neuroinflammatory Disorders
$389,213Shailendra Giri · Henry Ford Health System · R01 · FY2022 · AI
Mechanisms of Integrin-Mediated Costimulation in T Cells
$389,190Stephen C Bunnell · Tufts University Boston · R01 · FY2009 · AI
Mechanisms of White Matter Repair in Subcortical White Matter Ischemia
$389,167Stanley Thomas Carmichael · University Of California Los Angeles · R37 · FY2018 · NS
Growth Hormone Regulation of SH2B1
$389,156Christin Carter-Su · University Of Michigan At Ann Arbor · R01 · FY2011 · DK
PSYCHOSTIMULANTS FOR FATIGUE IN AMBULATORY MEN WITH PC
$389,068Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · CA
Exploring the consequences of the TNFRSF1A susceptibility allele for MS
$389,010Philip L De Jager · Brigham And Women'S Hospital · R01 · FY2009 · NS
Protective role of Clec7a/dectin-1 in CNS autoimmunity
$388,891Mari L. Shinohara · Duke University · R01 · FY2024 · NS
Treadmill Walking Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: A Systematically-Developed Randomized Controlled Trial
$388,889Brian M Sandroff · Kessler Foundation, Inc. · R01 · FY2021 · HD
Phase I Safety Interaction Trial of Ibudilast with Methamphetamine
$388,825Steven Shoptaw · University Of California Los Angeles · R01 · FY2011 · DA
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS
$388,797University Of Southern California · R01 · FY2002 · NS
Development and function of the meninges arachnoid barrier
$388,752Julie Siegenthaler · University Of Colorado Denver · R01 · FY2025 · NS